SEC Form 4 · accession 0001179110-17-012842

MOMENTA PHARMACEUTICALS INC · MNTA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President · Director

Period of report

Sep 28, 2017

Accepted (ET)

Oct 2, 2017 · 4:24 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001235010

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 28, 2017	M	25,667	$7.41	A	286,121	D
Common Stock^F2	Sep 28, 2017	S	25,667	$19.03	D	260,454	D
Common Stock^F3	Sep 28, 2017	S	10,000	$19.02	D	282,638	I	Craig Wheeler Revocable Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)	$7.41	Sep 28, 2017	M	25,667	D	May 22, 2008	Feb 22, 2018	Common Stock	25,667	25,666	D

F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2016.
F2This transaction was executed in multiple trades at prices ranging from $19.00 to $19.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3This transaction was executed in multiple trades at prices ranging from $19.00 to $19.125. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.